Document is current
Any future updates will be listed below
-
Authors
Volkov, M. https://orcid.org/0000-0001-7577-2994
Kampstra, A. S. B.
van Schie, K. A.
Kawakami, A.
Tamai, M.
Kawashiri, S.
Maeda, T.
Huizinga, T. W. J.
Toes, R. E. M.
van der Woude, D.
-
Funding
Funding for this research was provided by:
European Federation of Pharmaceutical Industries and Associations (777357)
ReumaNederland (LLP-5, 17-1-402)
Target2B! (LSHM18055-SGF)
European Research Council (AdG2019-884796)
PPP Allowance, Top Sector Life Sciences & Health to Samenwerkende Gezondheidsfondsen
- License Information
-
More Information
Article History
Received: 12 April 2021
Accepted: 28 November 2021
First Online: 8 December 2021
Declarations
:
: Animal experiments were approved by the Ethical Committee for Animal Experimentation of the LUMC, Leiden. The human serum of RA patients was collected during the IMPROVED study, which was approved by LUMC and all participating hospitals. Informed consent was obtained from all participants. The serum of individuals at risk of RA was collected as a part of the Nagasaki Island Study performed in Japan where it was approved by a regional ethic committee.
: Not applicable.
: The authors declare that they have no competing interests.
